Organogenesis Holdings Inc. (ORGO) Balance Sheet
As of 2026-06-30 (10-Q), Organogenesis Holdings Inc. (ORGO) reported total assets of $406.4M, total liabilities of $118.3M and shareholders' equity of $148.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $46.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ORGOOrganogenesis Holdings Inc.Follow ORGO — free
—
Price chart with a free account
- Market cap
- 127.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.9 | 2.4 | 21.4 | 60.4 | 84.8 | 114.5 | 102.5 | 103.8 | 135.6 | 93.7 | 46.1 | |
| Receivables | — | 28.1 | 34.1 | 39.4 | 56.8 | 82.5 | 89.5 | 82.0 | 109.9 | 217.5 | 100.9 | |
| Inventory | — | 14.3 | 13.3 | 22.9 | 27.8 | 25.0 | 24.8 | 28.3 | 26.2 | 29.6 | 29.3 | |
| Current assets | 1.4 | 49.7 | 71.1 | 125.6 | 174.3 | 227.0 | 222.6 | 225.0 | 285.9 | 362.2 | 200.3 | |
| Total assets | 311.4 | 148.7 | 163.7 | 220.7 | 290.2 | 443.3 | 449.4 | 460.0 | 497.9 | 598.7 | 406.4 | |
| Current liabilities | 0.5 | 52.0 | 56.1 | 59.9 | 68.2 | 82.7 | 75.0 | 80.5 | 77.5 | 100.1 | 57.0 | |
| Long-term debt | — | 0.6 | 0.6 | 0.0 | 60.0 | 74.1 | 71.3 | 66.6 | 0.0 | — | — | |
| Total liabilities | 11.3 | 157.3 | 116.6 | 165.1 | 148.4 | 201.9 | 183.7 | 181.4 | 112.6 | 164.8 | 118.3 | |
| Shareholders' equity | -16.0 | -15.3 | 39.9 | 52.0 | 141.8 | 241.3 | 265.7 | 278.7 | 262.9 | 300.1 | 148.3 |
USD millions · SEC XBRL
Organogenesis Holdings Inc. — questions
- How much cash does Organogenesis Holdings Inc. have?
- $46.1M in cash and cash equivalents as of 2026-06-30.
- What are Organogenesis Holdings Inc.'s total assets?
- $406.4M as of 2026-06-30.
- What is Organogenesis Holdings Inc.'s shareholders' equity?
- $148.3M as of 2026-06-30.
Every figure on this page comes from Organogenesis Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.